Polymorphisms in the Caspase genes and the risk of lung cancer

Journal of Thoracic Oncology

Volumn 5, Issue 8, 2010, Pages 1152-1158

  Lee, Shin Yup ^a   Choi, Yi Young ^b   Choi, Jin Eun ^b   Kim, Min Jung ^b   Kim, Jong Sik ^b   Jung, Deuk Kju ^b   Kang, Hyo Gyoung ^b   Jeon, Hyo Sung ^b   Lee, Won Kee ^b   Jin, Guang ^a,c   Cha, Seung Ick ^a   Kim, Chang Ho ^a   Jung, Tae Hoon ^a   Park, Jae Yong ^a,b  

^a Kyungpook National University Hospital   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c YANBIAN UNIVERSITY   (China)

Author keywords

Caspase; Genetic Susceptibility; Lung Cancer; Polymorphism

Indexed keywords

CASPASE 10; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9;

ADULT; ALLELE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER RISK; CONTROLLED STUDY; ENZYME ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ADENOCARCINOMA; CARCINOMA, LARGE CELL; CASE-CONTROL STUDIES; CASPASE 3; CASPASE 7; CASPASE 9; FEMALE; GENOTYPE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; SMALL CELL LUNG CARCINOMA; SURVIVAL RATE;

EID: 77955111893     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181e04543     Document Type: Article

References (26)

1. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
2. Webb SJ, Harrison DJ, Wyllie AH. Apoptosis: an overview of the process and its relevance in disease. Adv Pharmacol 1997;41:1-34.
3. Raff M. Cell suicide for beginners. Nature 1998;396:119-122.
4. Shivapurkar N, Reddy J, Chaudhary PM, et al. Apoptosis and lung cancer: a review. J Cell Biochem 2003;88:885-898.
5. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001;411:342-348.
6. Nicholson DW, Thornberry NA. Caspases: killer proteases. Trends Biochem Sci 1997;22:299-306.
7. Budihardjo I, Oliver H, Lutter M, et al. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999;15: 269-290.
8. Degterev A, Boyce M, Yuan J. A decade of caspases. Oncogene 2003;22:8543-8567.
9. Rhee H, Lee JS. PADB: published association database. BMC Bioinfor- matics 2007;8:348.
10. Wu X, Gu J, Grossman HB, et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet 2006;78:464-479.
11. Popanda O, Schattenberg T, Phong CT, et al. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 2004;25:2433-2441.
12. Beuten J, Gelfond JA, Franke JL, et al. Single and multigenic analysis of the association between variants in 12 steroid hormone metabolism genes and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2009;18:1869-1880.
13. Wang W, Spitz MR, Yang H, et al. Genetic variants in cell cycle control pathway confer susceptibility to lung cancer. Clin Cancer Res 2007;13: 5974-5981.
14. Chen K, Zhao H, Hu Z, et al. CASP3 polymorphisms and risk of squamous cell carcinoma of the head and neck. Clin Cancer Res 2008;14:6343-6349.
15. Lee WK, Kim JS, Kang HG, et al. Polymorphisms in the Caspase7 gene and the risk of lung cancer. Lung Cancer 2009;65:19-24.
16. Park JY, Park JM, Jang JS, et al. Caspase 9 promoter polymorphisms and risk of primary lung cancer. Hum Mol Genet 2006;15:1963-1971.
17. MacPherson G, Healey CS, Teare MD, et al. Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 2004;96:1866-1869.
18. Li C, Zhao H, Hu Z, et al. Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma. Hum Mutat 2008;29:1443-1451.
19. Son JW, Kang HK, Chae MH, et al. Polymorphisms in the caspase-8 gene and the risk of lung cancer. Cancer Genet Cytogenet 2006;169: 121-127.
20. Jang JS, Kim KM, Choi JE, et al. Identification of polymorphisms in the Caspase-3 gene and their association with lung cancer risk. Mol Car- cinog 2008;47:383-390.
21. Frank B, Hemminki K, Wappenschmidt B, et al. Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. Carcinogenesis 2006;27: 606-609.
22. Brennan P. Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? Carcinogenesis 2002;23:381-387.
23. Dempfle A, Scherag A, Hein R, et al. Gene-environment interactions for complex traits: definitions, methodological requirements and challenges. Eur J Hum Genet 2008;16:1164-1172.
24. Matullo G, Peluso M, Polidoro S, et al. Combination of DNA repair gene single nucleotide polymorphisms and increased levels of DNA adducts in a population-based study. Cancer Epidemiol Biomarkers Prev 2003; 12:674-677.
25. Lin J, Swan GE, Shields PG, et al. Mutagen sensitivity and genetic variants in nucleotide excision repair pathway: genotype-phenotype correlation. Cancer Epidemiol Biomarkers Prev 2007;16:2065-2071.
26. Ulybina YM, Kuligina ESh, Mitiushkina NV, et al. Coding polymorphisms in Casp5, Casp8 and DR4 genes may play a role in predisposition to lung cancer. Cancer Lett 2009;278:183-191.